Angle PLC
LSE:AGL
Angle PLC
LSE:AGL
Price:
17.75 GBX
29.09%
Market Closed
Updated:
May 6, 2024
Section:
Relative Value
The Relative Value of one
AGL
stock under the Base Case scenario is
13.88
GBX.
Compared to the current market price of 17.75 GBX,
Angle PLC
is
Overvalued by 22%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AGL
Relative Value
Base Case
13.88
GBX
Overvaluation 22%
Valuation Multiples
Multiples Across Competitors
AGL Competitors Multiples
Angle PLC Competitors
Angle PLC Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| UK |
|
Angle PLC
LSE:AGL
|
46.3m GBP | 25.4 | -2.1 | -1.2 | -1.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.6B USD | 4.6 | 32.6 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.3B USD | 18.5 | 68.1 | 55.8 | 70 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.1B USD | 6 | 37.2 | 24.2 | 29.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.6B USD | 3.4 | 25.9 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.8B USD | 7.3 | 60.5 | 30.8 | 45.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 3.5 | 55.6 | 18.6 | 39.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 2.7 | 38.1 | 18.3 | 30.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.3B USD | 8.4 | 36.3 | 26.4 | 28.5 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.8B USD | 13.4 | 79.5 | 59.5 | 77.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
